AIM2 and colorectal adenocarcinoma: (35) discovered that AIM2, a gene related to ICD, could inhibit the growth and metastasis of colon cancer cells in vivo, and colorectal adenocarcinoma patients with high expression of AIM2 had an enhanced response to immunotherapy.